186 related articles for article (PubMed ID: 35733332)
1. Correlation of BDNF, VEGF, TNF-α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients.
Chukaew P; Bunmak N; Auampradit N; Siripaiboonkij A; Saengsawang W; Ratta-Apha W
Neuropsychopharmacol Rep; 2022 Sep; 42(3):281-287. PubMed ID: 35733332
[TBL] [Abstract][Full Text] [Related]
2. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
3. Interaction of BDNF with cytokines in chronic schizophrenia.
Zhang XY; Tan YL; Chen DC; Tan SP; Yang FD; Wu HE; Zunta-Soares GB; Huang XF; Kosten TR; Soares JC
Brain Behav Immun; 2016 Jan; 51():169-175. PubMed ID: 26407757
[TBL] [Abstract][Full Text] [Related]
4. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the association between serum BDNF and cognitive impairment in schizophrenia patients using various antipsychotics.
Dong R; Zhao NO; Wu HE; Yu L; Zhang XY
J Psychiatr Res; 2021 Jun; 138():492-499. PubMed ID: 33971483
[TBL] [Abstract][Full Text] [Related]
6. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
Bora E
Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882
[TBL] [Abstract][Full Text] [Related]
7. Increased serum S100B in never-medicated and medicated schizophrenic patients.
Zhang XY; Xiu MH; Song C; Chen DC; Wu GY; Haile CN; Kosten TA; Kosten TR
J Psychiatr Res; 2010 Dec; 44(16):1236-40. PubMed ID: 20510426
[TBL] [Abstract][Full Text] [Related]
8. The microRNA-195 - BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure.
Pan S; Feng W; Li Y; Huang J; Chen S; Cui Y; Tian B; Tan S; Wang Z; Yao S; Chiappelli J; Kochunov P; Chen S; Yang F; Li CR; Tian L; Tan Y; Elliot Hong L
Transl Psychiatry; 2021 Feb; 11(1):117. PubMed ID: 33558459
[TBL] [Abstract][Full Text] [Related]
9. Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.
Chen S; Tian L; Chen N; Xiu M; Wang Z; Yang G; Wang C; Yang F; Tan Y
Psychiatry Res; 2017 Jan; 247():6-11. PubMed ID: 27863321
[TBL] [Abstract][Full Text] [Related]
10. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract][Full Text] [Related]
11. BDNF and S100B in psychotic disorders: evidence for an association with treatment responsiveness.
van de Kerkhof NW; Fekkes D; van der Heijden FM; Verhoeven WM
Acta Neuropsychiatr; 2014 Aug; 26(4):223-9. PubMed ID: 25142290
[TBL] [Abstract][Full Text] [Related]
12. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
Qi LY; Xiu MH; Chen DC; Wang F; Kosten TA; Kosten TR; Zhang XY
Neurosci Lett; 2009 Sep; 462(2):113-7. PubMed ID: 19539717
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
14. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
[TBL] [Abstract][Full Text] [Related]
15. Altered serum levels of vascular endothelial growth factor in first-episode drug-naïve and chronic medicated schizophrenia.
Ye F; Zhan Q; Xiao W; Tang X; Li J; Dong H; Sha W; Zhang X
Psychiatry Res; 2018 Jun; 264():361-365. PubMed ID: 29677618
[TBL] [Abstract][Full Text] [Related]
16. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia.
Carlino D; Leone E; Di Cola F; Baj G; Marin R; Dinelli G; Tongiorgi E; De Vanna M
J Psychiatr Res; 2011 Feb; 45(2):273-9. PubMed ID: 20630543
[TBL] [Abstract][Full Text] [Related]
17. Astroglial Mechanisms Underlying Chronic Insomnia Disorder: A Clinical Study.
Zhang P; Li YX; Zhang ZZ; Yang Y; Rao JX; Xia L; Li XY; Chen GH; Wang F
Nat Sci Sleep; 2020; 12():693-704. PubMed ID: 33117005
[TBL] [Abstract][Full Text] [Related]
18. Association of Tumor Necrosis Factor-Alpha with Psychopathology in Patients with Schizophrenia.
Pavlovic M; Babic D; Rastovic P; Arapovic J; Martinac M; Jakovac S; Barbaric R
Acta Med Okayama; 2023 Aug; 77(4):395-405. PubMed ID: 37635140
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
[TBL] [Abstract][Full Text] [Related]
20. S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia.
Rothermundt M; Ponath G; Glaser T; Hetzel G; Arolt V
Neuropsychopharmacology; 2004 May; 29(5):1004-11. PubMed ID: 14997170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
